Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Amplifi Vascular, Inc.

Amplifi Vascular, Inc.

Series APrairie Village, KSBiotechnology
Facts
Year of incorporation
2023sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
$6.8Msum of rounds with a disclosed amount only
Named investors
0
Financing history
3 rounds
  1. Oct 9, 2025
    Series A · $6.8M (disclosed)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval
  2. Aug 21, 2024
    Form D equity offering · $6.0M (form d sold) · 59 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Amplifi Vascular, Inc. filed Form D/A: $5,960,278 sold of $12,000,000, Biotechnology
  3. Jul 28, 2023
    Form D equity offering · $808,000 (form d sold) · 6 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Amplifi Vascular, Inc. filed Form D/A: $808,000 sold of $8,000,000, Biotechnology
Investors on record
0 edges
No named investor yet.
People
1 officers, 3 directors
Timeline
5
  1. Jun 30, 2026
    Amplifi Vascular, Inc. filed Form D/A: $5,960,278 sold of $12,000,000, Biotechnology
  2. Mar 26, 2026
    Amplifi Vascular, Inc. filed Form D/A: $5,910,278 sold of $6,000,000, Biotechnology
  3. Oct 9, 2025
    Amplifi Vascular announced Series A of $6,800,000
  4. Nov 27, 2024
    Amplifi Vascular, Inc. filed Form D: $1,543,619 sold of $4,000,000, Biotechnology
  5. Jun 25, 2024
    Amplifi Vascular, Inc. filed Form D/A: $808,000 sold of $8,000,000, Biotechnology
Evidence
61 observations
Every observation on this company